Keyphrases
Matrix metalloproteinase-9 (MMP-9)
100%
Serum Biomarkers
100%
High-grade Glioma
100%
YKL-40
100%
Hazard Ratio
27%
Tumor
27%
Glioblastoma multiforme
27%
Glioma Patients
27%
Serum Samples
18%
Anaplastic Glioma
18%
Surgical Resection
9%
Treatment Response
9%
Differentially Expressed
9%
Serum Levels
9%
Malignant Glioma
9%
Active Disease
9%
Patients with Cancer
9%
Serum Markers
9%
Postoperative Period
9%
Patient Demographics
9%
Inverse Association
9%
Survival Prediction
9%
Glioma
9%
Anaplastic Astrocytoma
9%
Patient Serum
9%
Magnetic Resonance Imaging Scan
9%
Prospective Longitudinal Study
9%
Neuroscience
MMP9
100%
Glioblastoma Multiforme
42%
Epileptic Absence
14%
Magnetic Resonance Imaging
14%
Longitudinal Study
14%
ELISA
14%
Astrocytoma
14%